Ground News

institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

optometrytimes.com image

News from optometrytimes.com

See all of optometrytimes.com’s headline news. Compare how the top news stories are covered by left-wing and right-wing news sources.

We’ve aggregated 201 of optometrytimes.com’s headlines and news stories over the past 3 months.

optometrytimes.com’s aggregated media bias check is unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

optometrytimes.com’s factuality rating is Unknown. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about optometrytimes.com

Where is optometrytimes.com located?optometrytimes.com's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top optometrytimes.com News

FDA Approves Tryptyr Eye Drops for Dry Eye Disease

FDA Approves Tryptyr Eye Drops for Dry Eye Disease

50% Center coverage: 42 sources

MONDAY, June 2, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved the first-in-class TRPM8 receptor agonist Tryptyr (acoltremon ophthalmic solution) for the treatment of signs and symptoms of dry eye disease.See the Story

FDA Approves Prednisolone Acetate Ophthalmic Suspension for Ocular Inflammation

FDA · United States

FDA Approves Prednisolone Acetate Ophthalmic Suspension for Ocular Inflammation

100% Center coverage: 1 sources

The FDA has approved preodnisolone acetate ophthalmic suspension, USP 1%, for treating steroid-responsive ocular inflammation. Amneal Pharmaceuticals plans to launch the product in Q3...See the Story

Qlaris Bio Announces Development of QLS-111-FDC

Qlaris Bio Announces Development of QLS-111-FDC

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.See the Story

Anthem agrees to pay $100,000 civil penalty following complaint filed in part by Maine Optometric Association

Anthem will also be required to conduct quarterly self-audits beginning in July of this year in order to document the correction of the issues stated in the report.Maine, United States · Maine Read Article

Individualizing optometry care to all patient populations

Bryce St. Clair, OD, MPH, authors the June edition of the Cultural Responsiveness Blog, and urges doctors to consider cultural and socioeconomic backgrounds when caring for patients.United States · United States See the Story

What you missed in glaucoma, dry eye, myopia, and more at CCS 2025

Presenters from the Collaborative Care Symposium 2025 give their key takeaways from their presentations.Read Article

EyeCare Partners releases Quality and Outcomes Report, highlights optometric successes

The report highlights clinical successes, innovation, research, and patient outcomes.Innovation Read Article

VBM reform efforts continue with latest bill introduction

The Vision Lab Choice Act of 2025, S 1716 was introduced to the US Senate floor on May 12.Senate · Washington Read Article

ZEISS fundus imaging device receives NMPA approval in China

CLARUS 700, the advanced retinal imaging system, captures 133 degrees in a single image and up to 267 degrees with multiple images.China · China See the Story

Mental Health Scores Decreased in Patients Who Developed POAG

Those who developed primary open-angle glaucoma (POAG) had lower mental health scores compared with those who had not developed the condition.See the Story

Researchers develop handheld device to improve early detection, treatment of amblyopia

The device was developed by Curators’ Distinguished Teaching Professor Carl Bassi and research collaborators Michael Howe and Wayne Garver of the University of Missouri – St Louis.St. Louis, United States · St. Louis Read Article

Breaking News Topics Related to optometrytimes.com